Objective: The Gass correction model removes 14 items from the MMPI-2 which refer to neurological damage when assessing a person suffering a traumatic brain injury (TBI). Previous analysis supported ongoing inclusion of the five correction items from MMPI-2 Hs scale in individuals who suffered a TBI. This study investigates the remaining nine correction model items on the Hy and Sc scales. Participants: A sample of patients with a TBI (n = 242), and the MMPI-2 normative sample (n = 2,600). Design: Main Measures: This is a cross-sectional study testing measurement invariance of two MMPI-2 scales (Hy and Sc) between the TBI and normative samples. Results: Factor models for each scale were defined and assessed across multiple samples. The Hy scale generated a four-factor model (CFI range .913-.935, RMSEA range .025-.027). The Sc scale generated a five-factor model (CFI range .911-.962, RMSEA range .013-.018). Both models met the criteria of partial measurement invariance. Sensitivity and specificity analysis supported retaining all correction items when assessing persons with a TBI. Conclusions: These results suggest continued inclusion of all 14 Gass correction model items when assessing a person with a TBI.
Introduction
Over 25 years ago Nelson et al. (1989) suggested that misinterpretation of neurological symptoms in individuals with traumatic brain injury (TBI) may generate spuriously inflated scores on diagnostic instruments. This position is reflected in the long-standing concern that neurological symptoms may be misconstrued as symptoms of psychopathology (Alfano, Paniak, & Finlayson, 1993; Caplan & Shechter, 1995; Gass & Russell, 1991; Rosenthal, Christensen, & Ross, 1998) . A specific example of these concerns is reflected in the hypothesis that the failure to account for the symptoms of neurological damage in the atheoretical development of the MMPI-2 may reduce the validity of the diagnostic instrument. This hypothesis led to the development of a correction model for TBI patients (Gass, 1991 ; from now on called the Gass correction model) and is included in some recent clinical assessment guides (e.g., Butcher, 2006; Graham, 2006) .
The intention of the Gass correction model is to remove the items that are thought to reduce the clinical validity of the MMPI-2 due to endorsement of items sensitive to neurological injury. The correction is achieved by excluding items thought to lead to a false-positive diagnosis. Notwithstanding this concern regarding false-positive diagnosis, an important counterpoint is that many patients suffering a TBI are battling the very psychopathology those "neurologic" symptoms may indicate. A clinician must be wary of dismissing the presence of such indications of psychopathology as inevitable effect of TBI and thereby miss the opportunity to provide necessary treatment (Al-Adawi et al., 2007; Gualtieri & Johnson, 1999) . This study aims to test the assertion of Nelson et al. by undertaking measurement invariance testing on the MMPI-2 with a sample of individuals who suffered a TBI.
The American Psychological Association guidelines stipulate that validity evidence is a necessary component of test development and usage (American Education Research Association,1999) . Therefore any alteration to the standard use of the MMPI-2 as part of a diagnostic procedure requires empirical support (Knapp & VandeCreek, 2006) . However, evaluation of the Gass correction model has produced conflicting results with some studies supporting the procedure (Gass & Wald, 1997; Gass, Luis, Rayls, & Mittenberg, 1999; Rayls, Mittenberg, William, & Theroux, 1997) . In contrast, others have concluded that the Gass correction model is inappropriate for persons with a TBI (Alkemade, Bowden, & Salzman, 2015; Brulot, Strauss, & Spellacy, 1997; Dunn & Lees-Haley, 1995; Edwards et al., 2003; Glassmire et al., 2003) .
These prior studies have used a variety of less direct or less rigorous techniques to assess the validity of the Gass correction model. For example, Gass and Wald (1997) supported the correction model because the correction items were reliable predictors of TBI sample membership versus membership of a non-TBI sample. However being an effective discriminator between the two samples may be due to factors associated with the TBI, such as the frequent comorbid psychopathology, rather than the TBI itself. Therefore while the analysis may conclude that the endorsement of a correction item is likely due to the effects of the TBI, this does not preclude the underlying cause of newly developed psychopathology. Edwards and colleagues (2003) focused on lack of changes in MMPI-2 code types after correction, concluding the correction procedure is unnecessary. Glassmire and colleagues (2003) used receiver operator characteristic curves to measure sensitivity and specificity of the correction procedure to identify participants in one of three sample, namely, normative, psychopathological, and TBI. Glassmire et al. found the analysis could separate the people with TBI from non-TBI participants, but not the people with TBI from people with psychopathology.
Implicit in the correction procedure hypothesis is the assumption that the underlying psychometric qualities of the MMPI-2 items, specifically the item-response characteristics, are altered when undertaking assessment of people who have suffered a TBI. A limitation of previous research on correction models is that with the exception of Alkemade and colleagues (2015) , most studies have not assessed the primary psychometric characteristics of the MMPI-2 items when applied to individuals suffering a TBI. The analytic technique of measurement invariance provides such a psychometric assessment. Measurement invariance assesses whether construct validity inferences from a diagnostic instrument have equivalent meaning across different populations both in terms of convergent and discriminant validity and in terms of deficit measurement (Horn & McArdle, 1992; Meredith, 1993; Widaman & Reise, 1997) . Examination of measurement invariance provides a direct test of the hypothesis that item-meaning differs across populations (Bowden et al., 2008; Brown, 2006; Jewsbury, Bowden, & Duff, 2016; Meredith & Teresi, 2006; Meredith, 1993; Widaman & Reise, 1997) . Although infrequently evaluated, measurement invariance is a fundamental aspect of test validity. It is essential for comparison of test score means across groups, and for uncomplicated interpretation of convergent and discriminant validity evidence. "Invariance of factor loadings across studied groups is required for valid comparisons of scale score or latent variable means…. for most applications in which the aim is to ensure fairness and equity, strict factorial invariance is required" (Meredith & Teresi, 2006, p. S69) . As the preceding quote illustrates, and since neuropsychological assessment seeks to be free from bias, establishing strict measurement invariance, that is equality of factor loadings, intercepts and residuals, is necessary. Additionally, establishing measurement invariance conveys strong information about the generalizability of construct validity information derived from one population, for example, a representative community or standardization sample, to other populations in which the test is applied. As Widaman and Reise (1997) note, if weak factorial or factor loading invariance applies "then group differences in latent-variable variances and covariances become identified in an [any rescaling factor-] invariant fashion… [for example] if one were to rescale the estimated within-group factor covariance matrices… into correlation matrices, the correlation matrices would be invariant …[so] any substantive interpretation of group differences in variances of covariances among latent variables will remain invariant over rescalings of the latent variables" (Widaman & Reise, 1997, p. 294) . All these latter implications from the mere observation of equality of factor loadings across groups.
The MMPI-2 underwent a substantial refinement in the early to mid 2000's, addressing concerns that the clinical scales overlapped greatly in the constructs being measured (Tellegen et al., 2003) . This overlap was partly due to design, whereby a single item could be located on multiple scales, and partly due to experiential overlaps of distress across various types of psychopathology. This process led to the development of the MMPI-2-RF (Ben-Porath & Tellegen, 2008) . It is worth noting that the MMPI-2-RF includes 9 of the14 items identified in the Gass correction model. Therefore, this measurement invariance analysis is an important step in continuing to assess the validity of this refined MMPI-2-RF instrument as well Examination of measurement invariance has been completed for the Hs scale which includes five items (101, 149, 175, 179, and 247) from the Gass correction model (Alkemade et al., 2015) . This previous study found the five items were psychometrically equivalent measures of psychopathology in people with and without a TBI, supporting the continued use of the items in the uncorrected scoring of the MMPI-2. In the current paper we aim to complete measurement invariance analysis on the Hy and Sc scales to assess whether the remaining nine items (31, 106, 147, 165, 170, 172, 180, 295, and 325) from the Gass correction model are appropriate for diagnosing psychopathology in persons suffering a TBI. The goal of the current paper is to build upon the Alkemade et al. findings and provide a completed measurement invariance evaluation of the neurologic content items identified in the Gass procedure, items that are thought to diminish the validity of the MMPI-2, and potentially the MMPI-2-RF as well. Completion of this analysis will help clinicians better understand how to manage the overlap of symptoms resulting from neurologic and psychopathological aetiologies when the diagnoses are possibly comorbid. Due to a combination of factors (i.e. the large numbers of items being analyzed, the large samples, and the computationally demanding nature of the analyses) the Hs and Sc scales will be analyzed separately.
Method

Participants and Materials
The MMPI-2 normative data comprises a USA representative community sample of adult men (n = 1,138) and women (n = 1,462). In the analysis of each scale (Hy and Sc), after removing cases with missing data, five samples were generated from the MMPI-2 normative data. The Female Norm sample included only female participants and the Male Norm sample included only male participants. Norm A and Norm B samples were randomly generated halves of the normative sample including mixtures of males and females. Finally, measurement invariance testing was completed with a Community sample of the MMPI-2 normative data that reflects the gender proportions observed in the full TBI sample (62.5% male and 37.5% female) described below. The Community sample was drawn from the standardization sample, consisting of the all participants in the Male Norm sample and a random subset of the participants from the Female Norm sample, to match the gender proportions in the TBI sample.
The sample of participants with a history of TBI had been assessed in a private practice specializing in forensic TBI evaluations who were tested using the MMPI-2 from 1995 to 2005. This sample comprises 162 males and 97 females collected consecutively and for whom MMPI-2 data were available. Conventional MMPI-2 validity rules were used to exclude patients with invalid profiles (i.e. CNS >30 raw score, VRIN or TRIN T-scores >80, or F or F B T-scores >110). In addition, the categorical item factor-analysis algebra requires exclusion of cases with any missing data. For the Hy scale 26 cases with missing item data or invalid profiles were removed leaving a final sample of n = 233 with a mean age of 36.0 years (SD = 13.1). The same procedure left a final sample for the Sc scale of n = 229 with a mean age of 35.8 years (SD = 12.8) after exclusion of 30 cases with missing item data or invalid profiles. Data on TBI severity was available for 212 participants, derived from the examining neuropsychologists report and stratified according to the criteria of Williamson, Scott, and Adams (1996) : 117 (55.2%) of participants had experienced mild injuries, 46 (21.7%) moderate, 32 (15.1%) moderately-severe and 17 (8%) severe injuries. A sample size of 200 per group is sufficiently powered to complete these analyses.
This study was granted approval by the Human Research and Ethics Committee of St Vincent's Hospital, Melbourne. See Table 1 for sample demographic information.
Procedure
Analyses were completed in a step-wise fashion. In this study, we analyzed two clinical scales sequentially. First was the Hy clinical scale, second was the Sc clinical scale. Duplicate items were removed from Hy and Sc to protect against repeated testing for the same item and to minimize computational difficulties from large item sets. With dichotomous data, the results of the measurement invariance testing with theta parameterization are equivalent to a test of differential item functioning under item-response theory (Glöckner-Rist & Hoijtink, 2003) . Therefore identifying differential item functioning on one scale would be expected to be replicated on any scale in which that item was included. After removing 20 items previously analyzed in common with the Hs scale, there are 40 items from Hy remaining for analysis. After removing 10 items previously analyzed with Hs or Hy, there are 68 items remaining for analysis from Sc. Items were rescored to account for polarity in preparation for practical impact analysis following the Millsap and Kwok (2004) approach.
Defining a Baseline Model
Measurement invariance testing requires a defined baseline model which must meet the criteria for configural invariance (Byrne, 1998; Widaman & Reise, 1997) . To define a baseline model exploratory factor analysis (EFA), then confirmatory factor analysis (CFA) in replication samples was completed using Mplus Version 6.11. Whilst the factor model is not the primary goal for this study it is a necessary precursor to be able to complete measurement invariance testing. The weighted least squares means and variance adjusted (WLSMV) estimator was employed as the estimation method for factor analysis. The procedure employed has been termed the "EFA into CFA" method (Floyd & Widaman, 1995) , to convert the best fitting, admissible EFA model into a simple structure CFA for replication across samples (Brown, 2006; Muthén & Muthén, 1998 -2010 .
We refer the interested reader to our original paper for a thorough account of the baseline model-definition procedure (see Alkemade et al., 2015) . In brief EFA and CFA were employed to define three candidate models: Norm A, Norm B (from a random split of the Normative MMPI-2 data) and TBI model (from the TBI sample). EFA was used to define the upper limit on number of factors and the allocation of items to a specific factor. CFA was then used to assess the admissibility of a factor model, along with the comparative goodness of fit of admissible factor models. All factor models were compared using the Root-Mean-Square-Error-Approximation (RMSEA), the Tucker-Lewis Index of fit (TLI), and the Comparative Fit Index (CFI) fit indices in line with Hu and Bentler's (1999) two-step approach to model selection. Once the preferred number of factors and item to factor loadings was determined, the model was evaluated for possible respecification to primarily account for method effects (Kline, 2010) . Additionally, the reallocation of any items to alternative factors was considered. At all times the goal is to define the best performing factor model in each sample without sacrificing parsimony.
Each candidate model was then subjected to a replication procedure in five separate samples using CFA. Performance of a factor model across a variety of samples is fundamentally important because of the risks of sample-specific solutions, especially when EFA is used for model development (Thomson, 2004) . The three samples used in the model development stage were augmented by the normative female and a normative male sample. If a candidate model failed the admissibility criteria during the replication stage then it was removed from further analysis and no longer available for selection as the baseline model. Admissible candidate models were compared for goodness of fit using RMSEA, CFI, and TLI. If no candidate model was found as preferred after this procedure, then candidate models were compared on measures of item reliability, factor articulation and a theoretical review of the candidate model structure.
Measurement Invariance Testing
Multi-group CFA was used for measurement invariance testing as it is the preferred methodology in multifactorial frameworks (Meade & Lautenschlager, 2004) . There were two samples used in the measurement invariance analysis for each scale, namely the Community sample and the TBI sample. With the MMPI-2, the parameters of interest are thresholds, loadings and residuals (Millsap & Yun-Tein, 2004 ). See Fig. 1 for details of how these parameters combine to create the measurement model for dichotomous items. Measurement invariance is established when the parameter estimates in the measurement model are constrained to equality and no loss of fit is observed. Measurement invariance testing sequentially holds the parameters of the measurement model to equality across the groups of interest. Provided model fit is equivalent with each additional constraint, then invariance is established. Constraint of parameters refers to the explicit definition in the multi-group CFA model that the defined parameters must be of identical numerical value across groups. Meade, Johnson, and Braddy (2008) propose a decrease in CFI of .002 or less as a threshold criterion to retain the assumption of invariance.
In measurement invariance Test 1 residuals are constrained to equality across groups with loadings and thresholds allowed to vary (except for loadings on marker variables). In measurement invariance Test 2 all residuals, loadings and threshold were constrained to equality across groups. Test 2 provides a test of strict invariance. If the CFI decreases by greater than .002, this test fails the requirement of strict measurement invariance. Should this occur then item parameters (loadings and thresholds) will be freed sequentially to find a model that meets the requirements of partial invariance. That is in Test 3, a factor model defined with the minimum number of parameters freed (or the maximum level of constraint), that meets the invariance criteria discussed above.
Review of the modification indices will show which item parameters are to be freed (Brown, 2006; Kline, 2010) . For more details regarding the procedure for each invariance test see Alkemade and colleagues (2015) .
Completing Practical Impact Analysis
The following section describes how the practical impact analysis designed by Millsap and Kwok (2004) was implemented for the MMPI-2 data. The interested reader should refer to the original paper for more information. Practical impact analysis for any factor that fails the test of strict invariance requires examination of the sensitivity and specificity values for the TBI sample in the strict and partial invariance conditions. Observed scores (calculated by summing the raw item scores) are proxy measures of diagnosis for the two samples, with or without presumed psychopathology. Factor scores (calculated by Mplus) are used to represent the presence or absence of psychopathology. These measures are required to calculate the sensitivity and specificity values.
To complete practical impact analysis, Millsap and Kwok (2004) show that the process requires selection of a cut-off score to differentiate those with and without psychopathology. An observed score and factor score that reflects the 93.32 percentile rank will be used to define cut-off points. This percentile rank is 1.5 standard deviations above the mean which corresponds to a T-score of 65 which is often used by the MMPI-2 to reflect a scores of clinical interest. A reference sample is required to define the cut-point scores (Millsap & Kwok) . In this study, the reference sample is the Community sample.
For each factor, individuals have a calculated observed score and factor score. A cut-off point for each factor score represents the presence or absence of psychopathology. For the same factor an observed score cut-point is defined to represent diagnostic assessment of psychopathology (present or absent). Therefore for each factor all participants were defined as above or below cut-off on psychopathology (factor scores), and above or below cut-off on diagnostic assessment (observed scores). These categories are used to generate a two by two frequency (true positive, true negative, false positive and false negative) table and to calculate the sensitivity and specificity.
This correct classification procedure is completed for both the partial invariance and the strict invariance conditions. The practical impact of non-invariant items is then evaluated by comparing the sensitivity and specificity values in the partial invariance condition (the clinical application of the MMPI-2) with the strict invariance condition (the desired condition of strict invariance across groups). Changes across conditions occur due to changes in the factor scores as a result of the differences in the partially-versus fully-invariant measurement model in the respective invariance conditions.
As the TBI population is populations for which the MMPI-2 validity is questioned, only the respective TBI sample sensitivity and specificity values are reviewed. The failure to observe strict invariance is suggested to have an important practical impact when the value of sensitivity or specificity in the partial invariance condition is below the lower bound of the 95% confidence interval (CI) in the strict invariance condition. The exception to this rule is when the absolute value for either sensitivity or specificity is acceptable in the partial invariance condition.
Results
Baseline Model
As a result of the model development and replication procedure described above, a 4-factor model from the Norm B sample [WLSMV χ 2 (725, N = 1248) = 1306.097 p < .0001] was selected as the Hy baseline model (see Table 2 ). The model fit for the selected model was acceptable across all replication samples CFI ranged .913-.935, RMSEA range .025-.027 The Norm A candidate model was found to be inadmissible during the replication analysis. A 5-factor TBI model did not fit the data as well during the replications procedures (see Table 3 ).
A 5-factor model from the Norm B sample [WLSMV χ 2 (2194, N = 1,227) = 2,649.038 p < .0001] was selected as the Sc baseline model (see Table 4 ). The model fit for the selected model was acceptable across all replication samples CFI ranged .911-.962, RMSEA range .013-.018 Again the Norm A candidate model was found to be inadmissible during the replication analysis. A 2-factor model was best fitting in the TBI sample, however in the replication analysis the fit indices generated by this candidate model were outside the criteria designated as indicating reasonable fit in two samples (see Table 5 ).
Measurement Invariance Testing
In Test 1, all residuals are held to equality across groups while loadings and thresholds are allowed to vary (except for loadings on marker variables). In Test 2, all residuals, loadings and threshold held to equality across groups, this is a test of strict invariance. If the model in test two fails to meet the invariance criteria then item parameters were freed for separate estimation across Community and TBI samples sequentially. Item loadings and then item thresholds are freed to find a model that meets the criteria of invariance. If necessary, Test 3 is the model with the minimum number of parameters unconstrained to meet the invariance criteria, this is a test of partial invariance. 7, 26, 44, 58, 76, 81, 110, 124, 135, 172, 193, 241, 253 and 263 "Reactions to others" 14, 29, 40, 98, 115, 116, 129, 151, 157, 213 and 218 "Shyness" 161, 167, 185, 243 and I265 23, 38, 42, 48, 138, 145, 168, 170, 177, 180, 182, 210, 229, 234, 268, 274, 292, 295, 296, 298, 299, 307, 311, 319, 322, 329, 333 and 355 2. Beliefs about family 6, 90, 192, 276 and 343 3. Unusual thoughts 16, 32, 34, 35, 85, 106, 221, 242, 287, 290, 316, 320, 323 and 332 4. Beliefs about self and others 12, 17, 21, 22, 46, 92, 190, 256, 273, 277, 278, 279, 280, 281, 291 and 303 5. Cognitive symptoms 147, 165, 233, 252 and 325 Hy scale. Invariance tests for detailed in Table 6 show Test 1 produced acceptable fit indices even with the residuals constrained to equivalence. Test 2 generated a decrease in the CFI value of .154, thus failing the test of strict invariance.
Parameters of the factor model were freed sequentially and allowed to vary across groups based on the modification indices. This procedure established that sequentially freeing loadings and thresholds for items 44, 193, 172, 29, 11, 253, 40, 263, 148, 241, 31, 14, 115, 124, 161, 185, 230, 129, 76, and135 was sufficient to meet the requirements for partial invariance (Test 3 in Table 6 ). That is the RMSEA was unchanged and the CFI decreased by .002 when compared with the fit indices generated in Test 1. There are two items from the Gass correction model loading on Hy and which are included in these analyses (31 and 172), both of which were identified as specific sources of variance (inequality of loading and threshold) across groups. These items loaded on only two of the four factors for Hy (see Table 2 ), therefore only these factors need be subject to the practical impact analysis, below.
Sc scale. Invariance tests detailed in Table 7 showed Test 1 produced acceptable fit indices even with the residuals constrained to equivalence. Test 2 generated a decrease in the CFI value of .121, thus failing the test of strict invariance. Again, parameters of the factor model were freed sequentially and allowed to vary across groups based on the modification indices. This procedure found that sequentially freeing loadings and thresholds for items 252, 210, 299, 355, 38, 274, 303, 290, 138, 322, 234, 170, 323, 332, 177, 242, 42, 182, 291, 92, 190, 281, 16, 287, 329, 278, 34 , and 17 was sufficient to meet the requirements for partial invariance (Test 3 in Table 7 ). That is the RMSEA was unchanged and the CFI decreased by .002 when compared with the fit indices generated in Test 1. There are seven items (106, 147, 165, 170, 180, 295, and 325 ) from the Gass (1991) correction procedure loading on Sc and which are included in this analysis. Of the seven only item 170 (from factor 1) was identified as a specific source of measurement model variance (inequality of loading and threshold) on the Sc scale. Therefore only this factor need be subject to the practical impact analysis, below.
Practical impact analysis. Hy scale-The practical impact analysis failed to support the hypothesis that the neurological and physical symptoms associated with a TBI inflated the classification error rate associated with the Hy scale. Two of the 40 items analyzed in this scale form part of the Gass (1991) correction procedure. They are items 31 (from factor 1) and 172 (from factor 2). When defining the partial invariance model both items required the respective loadings and thresholds to be freed. As can be seen in Table 8 , the practical impact analysis found support for retaining all items from factor 1 (including item 31) and factor 2 (including item 172). In factor 1 the sensitivity and specificity values are unchanged between the strict and partial invariance conditions. In factor 2 the specificity is higher in the partial invariance condition, while the sensitivity in the partial invariance condition value falls within the 95% confidence interval for the strict invariance condition. These observations fail to support the contention that the items identified by the Gass (1991) correction procedure lead to falsely inflated clinical scale score or false-positive diagnosis in the TBI population. 147, 165, 170, 180, 295, and 325 are part of the Gass (1991) correction procedure. Items 106, 147, 165, 180, 295 , and 325 met the criteria for strict invariance. Only item 170 (from factor 1) was identified as a specific source of measurement model variance on the Sc scale. Table 9 shows that for factor 1 the sensitivity value for the partial invariance condition was greater than the lower bound 95% CI for the strict invariance condition. Additionally the specificity value for the partial invariance condition was greater than the lower bound 95% CI for the strict invariance condition. These findings suggest for factor 1 there was no significant change to sensitivity or specificity from the failure to find strict invariance. The practical impact analysis supported retaining item 170. The results fail to support the contention that use of these items with a person suffering a TBI would falsely inflate scores on MMPI-2 profile, leading to an increase in false-positive diagnosis.
Discussion
We found a 4-factor model best represented the 40 items analyzed from Hy after excluding items that are in common with Hs. The four factors identified for Hy covered themes of "Mood", "Beliefs about others", "Reactions to others" and "Shyness", a literature search found no previous factor analyses of this scale in isolation with which to compare our results. Tests of measurement invariance were completed through comparison of endorsement patterns in a sample of patients suffering a TBI versus a gender matched subset of the MMPI-2 normative sample. The Hy 4-factor model met the criteria of partial invariance. Items 31 and 172 from the Gass (1991) correction procedure were among items that failed the test of strict Note: Values were calculated using the VassarStats calculator (Lowry, 1998 (Lowry, -2012 . Note: Values were calculated using the VassarStats calculator (Lowry, 1998 (Lowry, -2012 .
invariance. Importantly though, the factors which comprised both these items met the criteria for no practical impact when classification accuracy was examined under condition of partial versus strict measurement invariance. This finding supports the continued use or items 31 and 172 in the standard scoring procedure when assessing people with a TBI. Analysis of the Sc scale found a 5-factor model best represented the remaining 68 non-overlapping items. The five factors identified covered themes of "Unusual experiences & fearful thoughts", "Beliefs about family", "Unusual thoughts", "Beliefs about self and others", and "Cognitive symptoms." Again, a literature search found no previous factor analyses of this scale in isolation. Again, tests of measurement invariance were completed by comparing the endorsement patterns in a sample of patients suffering a TBI versus a gender matched subset of the MMPI-2 normative sample. And again, the Sc 5-factor model met the criteria for partial invariance. Seven items from the Gass (1991) correction procedure were part of Sc analysis. Six of these items (106, 147, 165, 180, 295, and 325 ) met the criteria of strict invariance. Only Item 170 failed the test of strict invariance but passed the tests of no practical impact (Table 6) .
In sum in this study, nine items from the Gass (1991) correction model for the MMPI-2 were investigated with measurement invariance analyses to test the proposition that items which refer to neurological symptoms will spuriously inflate MMPI-2 scores, thereby increasing the risking of false-positive diagnoses in individuals who have suffered a TBI. Six of the nine items met the criteria for measurement invariance which suggests they perform equivalently in TBI and non-TBI samples as measures of psychopathology. The practical impact analyses of the three remaining items found no evidence to suggest the slight variation in psychometric properties or differential item functioning of these items across groups of people with and without a TBI has any impact on the sensitivity or specificity of the measures when assessing for psychopathology.
The Gass (1991) correction model identifies 14 items distributed across Hs, Sc and Hy and proposes removal of these items from the MMPI-2 when assessing persons who have suffered a TBI. Our previous research (Alkemade et al., 2015) found no evidence for removal of the five items which form part of the Hs scale. That research in conjunction with the findings from this study shows that 11 of the 14 items are psychometrically equivalent (measurement invariant) when assessing persons with or without a TBI. This evidence alone is sufficient to conclude that clinicians should not use the Gass (1991) correction procedure in its original from, because 11 of the target items are invariant across community and TBI samples.
Regarding the remaining three Gass items, the tests of practical impact failed to reveal any impact on classification accuracy from inclusion of the three items (31, 170, and 172). For the Hy scale practical impact analysis found that despite the failure to find strict invariance for factor 1 (item 31) and factor 2 (item 172) there was no appreciable impact on the sensitivity and specificity values. The same findings were true for the practical impact analysis for factor 1 (item 170) on the Sc scale. The result being that none of the three Gass (1991) correction procedure items that failed the test of strict invariance were found to result in an important practical impact for the MMPI-2 in a sample of people with TBI where practical impact is measured in terms of diagnostic classification accuracy.
The goal of this study was to investigate the proposition that neurological symptoms associated with suffering a TBI diminish the validity of a test of psychopathology. The Gass (1991) correction procedure evolved from the entirely reasonable hypothesis that the use of items which refer to neurologic symptoms will invalidate tests for psychopathology by inflating false-positive symptom endorsement. As the MMPI-2 was designed using the criterion-keying approach it is a likely test of concern for the hypothesis of item misattribution in patients with conditions other than the targeted psychopathology. The Gass (1991) correction procedure implies that the 14 items selected for removal are sensitive to neurologic damage arising from a TBI and these items represent a specific source of failure of invariance (Gass, 2009) . Therefore a measurement invariance assessment of the Gass (1991) correction procedure is an important, direct evaluation of the hypothesis that items with neurological content in the MMPI-2 inflate the profiles of TBI patients. It is important to note that with 9 of the 14 items from the Gass correction procedure being included in the newer MMPI-2 RF, these results are also relevant for this updated version of the widely used test.
There are some limitations of this study which need consideration. Firstly is that the TBI sample is a private practice forensic sample which might raise some doubt as to the generalizability of the findings to the full spectrum of TBI patients. However in light of the results, any doubts could raise the need for an additional measurement invariance testing comparison sample, but not for continued use of the Gass correction procedure. Being involved in litigation may act as a mediating variable between injury and item endorsement (Senior & Douglas, 2001) . Therefore a non-forensic TBI sample could be used to replicate the analysis, or a non-TBI forensic sample could also control for the possible confound of litigation. While the sample was screened for invalid MMPI-2 profiles there was no use of cognitive performance validity tests to exclude participants. To infer that our results regarding the Gass correction items may have been qualified by an absence of performance validity test screening, it would be necessary to hypothesize specific impact of performance validity test failure on the respective items. We are not aware that anyone has ever hypothesized this or a similar, relevant effect.
In summary, the measurement invariance analyses, which also served as differential item functioning analyses, found 11 of the 14 Gass correction model items were psychometrically equivalent in a sample of individuals who suffered a TBI, and in the MMPI-2 normative data sample. Additionally for the three items which failed the test of strict invariance, practical impact analysis found there was no functional impact on the sensitivity and specificity of the MMPI-2 scales. The only conclusion supported by the data is that items with neurologic content are not unduly biasing the psychopathology assessment profiles of patients with a TBI.
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